

A complete guide to Hadlima side effects, from common injection site reactions to serious warnings. Know what to watch for and when to call your doctor.
Starting a new biologic medication like Hadlima (adalimumab-bwwd) comes with questions — and worrying about side effects is completely normal. The good news is that most people tolerate Hadlima well, and many side effects are mild and manageable. But because Hadlima affects your immune system, there are some serious risks you should understand before starting treatment.
This guide covers both the common and serious side effects of Hadlima based on FDA-approved labeling, so you know exactly what to watch for.
Hadlima is a biosimilar to Humira (adalimumab) made by Organon. It's a TNF blocker — a type of biologic that reduces inflammation by targeting a protein called tumor necrosis factor-alpha (TNF-alpha). It's used to treat autoimmune conditions like rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, and several others.
Because Hadlima is a biosimilar, its safety profile is essentially the same as Humira's. The side effects listed here are based on clinical trials and post-marketing data for adalimumab products.
These side effects are reported frequently in clinical trials and are generally mild to moderate:
Most of these side effects don't require you to stop treatment. If they're bothersome, talk to your doctor about management strategies.
Hadlima carries a boxed warning — the most serious type of FDA warning — for two major risks:
Because Hadlima suppresses part of your immune system, it increases your risk of serious infections. These can include:
When to call your doctor: Contact your doctor immediately if you develop a fever, chills, persistent cough, night sweats, unexplained weight loss, or any signs of infection while taking Hadlima.
TNF blockers have been associated with an increased risk of certain cancers:
Hadlima is not recommended during pregnancy because it may affect the immune response of the developing baby. If you become pregnant while taking Hadlima, contact your doctor right away. Hadlima is present in breast milk at low levels — discuss the risks and benefits with your doctor if you plan to breastfeed.
Hadlima is approved for juvenile idiopathic arthritis in children 2 years and older and Crohn's disease in children 6 years and older. The boxed warning about malignancy is particularly important in pediatric patients.
Patients over 65 have a higher risk of infections while on Hadlima. Closer monitoring may be needed.
Here are practical tips for dealing with the most frequent side effects:
For a fuller picture of how Hadlima works in your body, see our mechanism of action guide. And if cost is a concern, check our savings guide — because side effects are easier to manage when you can actually afford your medication.
Hadlima is an effective treatment for many autoimmune conditions, and most patients tolerate it well. The common side effects — injection site reactions, headaches, and minor infections — are manageable for most people. The serious risks, while real, are relatively rare and are monitored through regular check-ups and lab work.
The key is to stay informed and stay in contact with your doctor. Report any unusual symptoms promptly, keep up with your scheduled blood tests, and don't skip your TB screening. With the right monitoring, many people take Hadlima safely for years.
Looking for Hadlima near you? Check availability on Medfinder.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.